These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17125700)

  • 41. Smooth muscle hyperplasia in an asthmatic patient: do we know it all?
    Ergan-Arsava B; Karakaya G; Firat P; Kalyoncu AF
    Respiration; 2011; 81(2):152-6. PubMed ID: 20664253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myofibroblast and elastic and collagen fiber hyperplasia in the bronchial mucosa: a possible basis for the progressive irreversibility of airway obstruction in chronic asthma.
    Gabbrielli S; Di Lollo S; Stanflin N; Romagnoli P
    Pathologica; 1994 Apr; 86(2):157-60. PubMed ID: 7936758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mast cell numbers in airway smooth muscle and PC20AMP in asthma and COPD.
    Liesker JJ; Ten Hacken NH; Rutgers SR; Zeinstra-Smith M; Postma DS; Timens W
    Respir Med; 2007 May; 101(5):882-7. PubMed ID: 17097865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bronchial morphologic modification in asthma].
    Cataldo D; Louis R; Godon A; Munaut C; Noël A; Foidart JM; Bartsch P
    Rev Med Liege; 2000 Jul; 55(7):715-20. PubMed ID: 11014106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistology in bronchial asthma.
    Aalbers R; Smith M; Timens W
    Respir Med; 1993 Aug; 87 Suppl B():13-21. PubMed ID: 8234961
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of peroxisome proliferator-activated receptor-gamma on airway smooth muscle thickening in a murine model of chronic asthma.
    Rhee CK; Lee SY; Kang JY; Kim SJ; Kwon SS; Kim YK; Park SH
    Int Arch Allergy Immunol; 2009; 148(4):289-96. PubMed ID: 19001788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Airway remodeling in asthma.
    Sumi Y; Hamid Q
    Allergol Int; 2007 Dec; 56(4):341-8. PubMed ID: 17965577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventive therapy of asthma steroid and other antiasthmatic drugs.
    Nagy L
    Acta Microbiol Immunol Hung; 1998; 45(1):131-4. PubMed ID: 9595163
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of intranasal corticosteroid treatment on asthma in children and adults.
    Durham SR
    Allergy; 1999; 54 Suppl 57():124-31. PubMed ID: 10565488
    [No Abstract]   [Full Text] [Related]  

  • 50. [Application of adrenal cortex hormones in the treatment of asthma].
    Nakajima A
    Nihon Naika Gakkai Zasshi; 1992 Jun; 81(6):846-9. PubMed ID: 1402239
    [No Abstract]   [Full Text] [Related]  

  • 51. Exhaled nitric oxide and bronchial wall thickening in asthmatics during and after acute exacerbation: evidence of bronchial wall remodeling.
    Ketai L; Harkins M; Fiato KL; Iwamoto GK
    J Asthma; 2005 Oct; 42(8):667-71. PubMed ID: 16266958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Asthma as an inflammatory disease: clinical perspectives.
    Chung KF; Durham SR
    Br Med Bull; 1992 Jan; 48(1):179-89. PubMed ID: 1617390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Airway smooth muscle hypertrophy and hyperplasia in asthma.
    James A; Mauad T; Abramson M; Green F
    Am J Respir Crit Care Med; 2012 Sep; 186(6):568; author reply 569. PubMed ID: 22984027
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of the large airways on smooth muscle contraction in asthma.
    Permutt S
    J Appl Physiol (1985); 2007 Oct; 103(4):1457-8. PubMed ID: 17540837
    [No Abstract]   [Full Text] [Related]  

  • 55. Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma.
    Morin C; Fortin S; Cantin AM; Rousseau E
    Am J Respir Cell Mol Biol; 2011 Aug; 45(2):366-75. PubMed ID: 21057106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction in peripheral blood eosinophil counts after bronchial thermoplasty.
    Ryan DM; Fowler SJ; Niven RM
    J Allergy Clin Immunol; 2016 Jul; 138(1):308-310.e2. PubMed ID: 26953157
    [No Abstract]   [Full Text] [Related]  

  • 57. Bronchial hyperresponsiveness today.
    Sterk PJ
    Respir Med; 1993 Aug; 87 Suppl B():27-9. PubMed ID: 8234964
    [No Abstract]   [Full Text] [Related]  

  • 58. Intense pharmacotherapy.
    Zeiss CR
    Chest; 1992 Jun; 101(6 Suppl):407S-409S. PubMed ID: 1591941
    [No Abstract]   [Full Text] [Related]  

  • 59. Improving asthma treatment: the physiological message.
    Sterk PJ
    Eur Respir J; 1994 Feb; 7(2):220-2. PubMed ID: 8162973
    [No Abstract]   [Full Text] [Related]  

  • 60. SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice.
    Chiba Y; Takeuchi H; Sakai H; Misawa M
    J Pharmacol Sci; 2010; 114(3):304-10. PubMed ID: 20948165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.